BIO-key Int.

BIO-key International, Inc. engages in the provision of identity and access management (IAM) platform.The firm's products include multi-factor authentication, self-service password reset, single sign-on, fingerprint scanners, and civil and large-scale identification.It offers its services to the education, financial, government, healthcare, manufacturing, and retail industries.The company was founded on January 7, 1993 and is headquartered in Wall, NJ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

BIO-key Boosts Revenue, Launches New IAM Product

BIO-key International has shown notable improvements in its financial and operational performance in Q1 2024, marked by increased revenues, higher profit margins, and reduced losses. The company's strategic initiatives and new product launches are set to address the expanding market needs in identity management, despite facing challenges related to inventory management and market competition.

BIO-key reports Q2 revenue decline, focuses on growth strategies

BIO-key's Q2 2024 performance was impacted by revenue decline from software contract delays.
Despite challenges, the company showcased strengths in new product offerings and global market expansion.
Opportunities lie in strategic partnerships and CEO optimism for future growth and profitability.

BIO-key Int. (BKYI) reports robust Q3 performance and growth opportunities

BIO-key International demonstrated strong revenue growth and margin improvements in Q3 '24, driven by high-margin license revenue and cost controls.
The company's focus on enhancing security, reducing fraud, and expanding market reach through strategic partnerships positions them for future success.
While challenges in achieving profitability persist, BIO-key's strategic initiatives and focus on recurring revenues offer promising growth prospects.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BIO-key International, Inc. engages in the provision of an identity and access management platform. The firm's products include PortalGuard, Admin Panel, Hardware, Identity-Bound Biometrics, and MobileAuth. It offers its services to the education, finance, government, healthcare, manufacturing, and retail industries. The company was founded on January 7, 1993 and is headquartered in Holmdel, NJ.

BIO-key International, Inc. (NASDAQ:BKYI ) Q3 2024 Earnings Conference Call November 15, 2024 10:00 AM ET Company Participants William Jones - IR Michael DePasquale - Chairman & CEO Cecilia Welch - CFO Conference Call Participants Jack Vander Aarde - Maxim Group Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's 2024 Third Quarter Conference Call.

BIO-key International, Inc. (BKYI) Q3 2024 Earnings Call Transcript

BIO-key (BKYI) Reports Q3'24 Revenue Rose 18% to $2.1M, Reduced Q3'24 Net Loss, Improved Cash Position; Hosts Conf. Call Tomorrow, Fri. Nov. 15th, 10am ET.

BIO-key Reports Q3'24 Revenue Rose 18% to $2.1M, Reduced Q3'24 Net Loss, and Improved Cash Position; Hosts Investor Call Tomorrow, Fri. Nov. 15th, 10am ET

HOLMDEL, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless and phish-resistant authentication, announced that it has received a $910,000 order from a long-term financial services customer to upgrade to BIO-key's “fingerprint only” Biometric Customer Identification Technology.

BIO-key Secures $910,000 Order to Upgrade Long-Time Financial Services Customer to Enhanced Biometric Customer Identification Technology

BIO-key Accelerates Zero Trust Solutions at Industry-Leading Cybersecurity Conference, ISC2 Security Congress 2024, incl. hosting a session on Passkeys.

BIO-key Accelerates Zero Trust Solutions at Industry-Leading Cybersecurity Conference, ISC² Security Congress 2024

BIO-key, International (BKYI) Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control.

BIO-key Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control

HOLMDEL, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless and phish-resistant authentication experiences, today announced it has entered into a warrant inducement agreement with an existing institutional investor for the immediate exercise of certain outstanding warrants that the Company issued on October 30, 2023.

BIO-key International Enters into $1.9 Million Warrant Inducement

HOLMDEL, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless and phish-resistant authentication experiences, announced that one of the world's most respected government defense ministries has awarded BIO-key over $500K in new orders for BIO-key's biometric user authentication solution pursuant to a three-year purchasing agreement.

Leading Government Defense Ministry Awards BIO-key $500K In Follow-On Orders for Biometric User Authentication

HOLMDEL, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software featuring passwordless, phoneless and token-less Identity-Bound Biometrics (IBB) authentication solutions, will participate at H.C.

Identity and Access Management Software Provider BIO-key to Participate at H.C. Wainwright Investment Conf.

BIO-key International, Inc. (NASDAQ:BKYI ) Q2 2024 Earnings Conference Call August 15, 2024 10:00 AM ET Company Participants Bill Jones - Investor Relations Mike DePasquale - Chairman and Chief Executive Officer Cecilia Welch - Chief Financial Officer Conference Call Participants Jack Vander Aarde - Maxim Group Operator Good morning, everyone. Thank you for standing by and welcome to the BIO-key International First Quarter 2024 Conference Call.

BIO-key International, Inc. (BKYI) Q2 2024 Earnings Call Transcript

$BKYI BIO-key's PortalGuard Identity Access Management Solution & Identity-Bound Biometrics Are Now Available on the Amazon Web Services (AWS) Marketplace

BIO-key's PortalGuard Identity and Access Management Solution and Identity-Bound Biometrics Are Now Available on the Amazon Web Services (AWS) Marketplace

HOLMDEL, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its second quarter ended June 30, 2024 (Q2'24). Note, BIO-key's results for 2023 were restated at year-end and filed with the Company's 2023 Form 10-K, and as a result Q2'23 and six months ended June 30, 2023 comparisons in this release have been restated. BIO-key will host an investor call Thursday, August 15th at 10:00am ET (details below).

BIO-key Reports Reduced Net Loss and Cash Used in Operations on Lower Q2'24 Revenues; Hosts Investor Call Thu. Aug. 15th at 10am ET

HOLMDEL, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q2 2024 investor call Thursday, August 15th at 10 a.m.

Identity and Access Management Solutions Provider BIO-key Hosts Q2 Investor Call Thursday, August 15th at 10am ET

Williamsburg, Virginia Advances Zero Trust Initiative (Cyber Security) for City's Software Infrastructure and Data with BIO-key's Identity-Bound Biometrics

Williamsburg, VA Advances Zero Trust Initiative for City Infrastructure and Data with BIO-key Identity-Bound Biometrics

BIO-key International, Inc. (NASDAQ:BKYI ) Q1 2024 Earnings Conference Call June 18, 2024 10:00 AM ET Corporate Participants Bill Jones - Investor Relations Mike DePasquale - Chairman and Chief Executive Officer Ceci Welch - Chief Financial Officer Jim Sullivan - Chief Legal Officer Conference Call Participants Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's First Quarter 2024 Conference Call.

BIO-key International, Inc. (BKYI) Q1 2024 Earnings Call Transcript

HOLMDEL, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q1 2024 investor call Tuesday, June 18th at 10 a.m.

Identity, Access Management and Cybersecurity Solutions Provider BIO-key International Hosts Q1 Investor Call Tues., June 18th at 10am ET

Identity, Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9am ET

Identity and Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9:00am ET

WALL, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that on May 22, 2024, it received a letter (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (“SEC”), due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the “Form 10-Q”). The Notification Letter has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market.

BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq

HOLMDEL, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, today announced that it currently expects to file its audited 2023 results with the SEC on Form 10-K next week.

BIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next Week

HOLMDEL, N.J. and SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less FIDO and Passkey authentication solutions through its unique Identity Bound Biometrics (IBB) capabilities, is proud to announce it has won the Hot Company Multi-Factor Authentication award from Cyber Defense Magazine (CDM), the industry's leading electronic information security magazine.

BIO-key Wins Coveted Global InfoSec Award for Multi-factor Authentication During RSA Conference 2024

Switzerland's Canton of Ticino has partnered with Asecus AG to Implement BIO-key's Multi-Factor Authentication Solution in its Information Systems Center

Switzerland's Canton of Ticino Implements BIO-key's Multi-Factor Authentication Solution in its Information Systems Center

BIO-key International, Inc. (NASDAQ:BKYI ) Q4 2023 Earnings Conference Call April 2, 2024 10:00 AM ET Company Participants Bill Jones - IR Mike DePasquale - Chairman and CEO Ceci Welch - CFO Conference Call Participants Jack Vander Aarde - Maxim Group Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's Fourth Quarter 2023 Conference Call.

BIO-key International, Inc. (BKYI) Q4 2023 Earnings Call Transcript

Identity Access Management Software Provider BIO-key Preliminary 2023 Results: Operating Loss Trimmed Approx. $3.5M on Approx. 29% Revenue Growth to $9.1M.

Identity and Access Management Software Provider BIO-key Preliminary 2023 Results: Operating Loss Trimmed Approx. $3.5M on Approx.

Identity and Access Management/Cybersecurity Solutions Provider BIO-key International Hosts Q4 Investor Call Tues., Apr. 2nd at 10am ET. 1-877-418-5460.

Identity and Access Management/Cybersecurity Solutions Provider BIO-key International Hosts Q4 Investor Call Tues., Apr. 2nd at 10am ET

DUBAI, United Arab Emirates and HOLMDEL, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Humanity International Investments (HII) and BIO-key® International, Inc. (NASDAQ: BKYI), announce significant milestones in HII's innovative Humanity Protocol initiative.

Humanity International Investments Hits Major Milestones in Digital Identity with the Humanity Protocol Initiative in Partnership with BIO-key International

HOLMDEL, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software infrastructure featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, announced that a long-term financial services customer has executed a two-year, pre-paid $1.5 million agreement for the ongoing use and expanded deployment of BIO-key's biometric customer identification technology.

News for BIO-key Int. Stock (BKYI)